Financial giants have recently made a stark bearish move on Harrow. An analysis of options history for Harrow (NASDAQ: HROW) has uncovered 13 intriguing trades.
Diving into the details, it emerges that 38% of traders have shown bullish inclinations, while 46% have leaned towards bearish sentiments. Among the trades identified, 3 were puts valued at $1,214,425, and 10 were calls valued at $496,874.
Insights into Price Projections
Meticulously analyzing the Volume and Open Interest on these contracts reveals that significant market players have set their sights on a price range spanning from $12.0 to $35.0 for Harrow over the past 3 months.
Analyzing Volume & Open Interest Dynamics
Scrutinizing volume and open interest represents a crucial strategic step in options trading. These metrics offer valuable insights into the liquidity and investor engagement surrounding Harrow’s options at specific strike prices. Let’s now delve into the fluctuation patterns in volume and open interest for both calls and puts, relating to Harrow’s substantial trades within the strike price spectrum of $12.0 to $35.0 over the preceding 30 days.
Tracking Harrow’s Options Volume And Open Interest Over the Last 30 Days
Standout Options Trades Revealed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HROW | PUT | TRADE | BEARISH | 10/18/24 | $2.85 | $1.85 | $2.85 | $30.00 | $1.1M | 0 | 4.0K |
| HROW | CALL | SWEEP | BEARISH | 01/17/25 | $5.9 | $5.8 | $5.8 | $35.00 | $69.5K | 104 | 133 |
| HROW | CALL | SWEEP | BULLISH | 01/17/25 | $9.0 | $8.0 | $8.0 | $30.00 | $69.5K | 884 | 279 |
| HROW | CALL | SWEEP | BEARISH | 01/17/25 | $7.5 | $6.8 | $6.8 | $35.00 | $68.0K | 104 | 664 |
| HROW | CALL | TRADE | BULLISH | 10/18/24 | $20.5 | $20.4 | $20.5 | $12.00 | $61.5K | 339 | 40 |
About Harrow
Harrow Inc is an eyecare pharmaceutical company actively involved in the discovery, development, and commercialization of ophthalmic pharmaceutical products tailored for the U.S. market. The company aims to assist U.S. eyecare professionals in safeguarding the precious gift of vision by ensuring the accessibility and affordability of its wide range of prescription and non-prescription pharmaceutical products for millions of Americans.
Current Position of Harrow
- With a trading volume of 2,831,190, HROW’s price has surged by 54.28%, now standing at $33.91.
- Current RSI indicators suggest a potential overbought status for the stock.
- The next earnings report is slated for 95 days from today.
Options, being a more speculative investment compared to stock trading, offer increased profit potential. Seasoned options traders effectively manage this risk by staying informed daily, strategically entering and exiting trades, considering multiple indicators, and closely monitoring market movements.
